Article
Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy.
Rheumatology international - 1 Jun 2012
McGeough Cathy M, Berrar Daniel, Wright Gary, Mathews Clare, Gilmore Paula, Cunningham Rodat T, Bjourson Anthony J
Abstract excerpt
The identification of patients who will respond to anti-tumor necrosis factor alpha (anti-TNF-α) therapy will improve the efficacy, safety, and economic impact of these agents. We investigated whether killer cell immunoglobulin-like receptor (KIR) genes are related to response to anti-TNF-α therapy in patients with rheumatoid arthritis (RA). Sixty-four RA patients and 100 healthy controls were genotyped for 16...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
